Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using Uvr proteins we have quantified benzo(a)pyrene diol epoxide (BPDE)-DNA adduct formation and repair at the
dihydrofolate reductase
(
DHFR
) and adenine phosphoribosyltransferase (APRT) genes in two Chinese hamster ovary cell lines: B-11 cells, which are 50-fold amplified for
DHFR
, and
AT3
-2 cells, which are diploid for
DHFR
. We have found that: 1) BPDE-DNA adduct formation in different regions of the
DHFR
gene is proportional to the concentration of BPDE. 2) There is no significant difference in the repair of BPDE-DNA adducts between the coding and noncoding regions in either amplified or nonamplified
DHFR
gene domains. 3) Repair in the nonamplified
DHFR
gene is more efficient (30-40%) than in the amplified
DHFR
genes. 4) There are no significant differences of repair in the transcribed or nontranscribed strands of the
DHFR
gene. 5) BPDE-DNA adduct formation and repair in the APRT gene in B-11 and
AT3
-2 cells are the same. These results contrast those for the repair of cyclobutane pyrimidine dimers, which occurs preferentially in the transcribed strand of the
DHFR
gene and in which gene amplification appears to play no role.
...
PMID:Repair of benzo(a)pyrene diol epoxide- and UV-induced DNA damage in dihydrofolate reductase and adenine phosphoribosyltransferase genes of CHO cells. 817 87